Crepaldi Carlo, Soni Sachin, Chionh Chang Yin, Wabel Peter, Cruz Dinna N, Ronco Claudio
Contrib Nephrol. 2009;163:1-6. doi: 10.1159/000223772. Epub 2009 Jun 3.
Assessment of body fluids in peritoneal dialysis is an important issue in the treatment of renal failure. Overhydration is related with hypertension and left ventricular hypertrophy and dehydration leads to hypotension and reduction of residual renal function. Bioimpedance analysis (BIA) provides objective information in assessment of hydration status of the patients. In the past BIA was not widely used in patients undergoing peritoneal dialysis. Our aim was to estimate the status of hydration in our peritoneal dialysis population by body composition monitoring (BCM) device to modify our pharmacological and dialysis policy. We used a Fresenius Body Composition Monitor, a whole-body bioimpedance spectroscopy (50 frequencies, 5-1,000 kHz ), to assess the body composition of 97 patients on peritoneal dialysis in our center. The patients were subjected to a physical examination every three months: We measured body weight, 24 h diuresis and performed a BIA session. BIA measurements were repeated according to different clinical situations. Every patient underwent BIA at least on two different occasions. Our preliminary results have found a strict correlation between weight increase or decrease and the results (total body water, extracellular water, lean mass index) shown by BCM. Modifications of therapy in patients dehydrated restored a satisfying amount of diuresis. Hypertensive overhydrated patients changed their scheduled treatment improving their blood pressure and achieving a lower body weight. Bio impedance analysis is the most reliable, repetitive, not invasive, simple, portable and relatively inexpensive technique to assess the fluid status of a dialysis patient is bioimpedance.
评估腹膜透析患者的体液情况是肾衰竭治疗中的一个重要问题。水合过度与高血压及左心室肥厚有关,而脱水则会导致低血压和残余肾功能减退。生物电阻抗分析(BIA)为评估患者的水合状态提供了客观信息。过去,BIA在接受腹膜透析的患者中并未得到广泛应用。我们的目的是通过身体成分监测(BCM)设备评估我们腹膜透析人群的水合状态,以调整我们的药物治疗和透析策略。我们使用费森尤斯身体成分监测仪,一种全身生物电阻抗光谱仪(50个频率,5 - 1000千赫兹),来评估我们中心97例腹膜透析患者的身体成分。患者每三个月接受一次体格检查:我们测量体重、24小时尿量,并进行一次BIA检测。根据不同临床情况重复进行BIA测量。每位患者至少在两个不同时间点接受BIA检测。我们的初步结果发现体重增加或减少与BCM显示的结果(总体水、细胞外液、瘦体重指数)之间存在密切相关性。对脱水患者治疗方案的调整恢复了令人满意的尿量。高血压性水合过度患者改变了他们的既定治疗方案,血压得到改善,体重降低。生物电阻抗分析是评估透析患者体液状态最可靠、可重复、无创、简单、便携且相对便宜的技术。